KRAS mutational status impacts pathologic response to pre-hepatectomy chemotherapy: a study from the International Genetic Consortium for Liver Metastases Margonis, G. A., Amini, N., Andreatos, N., Sasaki, K., Mcvey, J., Mirza, M. B., Warner, S., Buettner, S., Barbon, C., Wang, J., Pulvirenti, A., Angelou, A., Kamphues, C., Antoniou, E., Pikoulis, E., Pawlik, T. M., Kaczirek, K., Poultsides, G., Wagner, D., Endo, I., Imai, K., Aucejo, F., Kreis, M. E., Wolfgang, C. L., Weiss, M. J. ELSEVIER SCI LTD. 2019: 1527–34

View details for DOI 10.1016/j.hpb.2019.03.368

View details for Web of Science ID 000496805100015